94 related articles for article (PubMed ID: 8073952)
1. [Effects of nephrectomy and interferon administration on immunological parameters in patients with renal cell carcinoma].
Arima K; Yanagawa M; Sugimura Y; Tochigi H; Kawamura J; Saitoh K; Yamazaki Y; Mori O; Oomoto Y; Nakagawa M
Hinyokika Kiyo; 1994 Jun; 40(6):469-74. PubMed ID: 8073952
[TBL] [Abstract][Full Text] [Related]
2. [Immunological assessment after radical nephrectomy for renal cell carcinomas pre-treated with interferon-gamma].
Onishi T; Machida T; Masuda F; Igarashi H
Hinyokika Kiyo; 1991 Jul; 37(7):671-8. PubMed ID: 1927765
[TBL] [Abstract][Full Text] [Related]
3. [Long-term immunological study on postoperative adjuvant treatment with interferon-gamma in patients with renal cell carcinoma who underwent nephrectomy].
Miura H; Arai H; Matsuoka A; Yazawa K; Satoh E; Nishimura K; Honda M; Fujioka H
Hinyokika Kiyo; 1999 Feb; 45(2):79-83. PubMed ID: 10212778
[TBL] [Abstract][Full Text] [Related]
4. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
Yasunaga Y; Nishimura K; Miura H; Takatera H; Kuroda H; Kishimoto T; Fujioka H
Hinyokika Kiyo; 1995 Feb; 41(2):85-92. PubMed ID: 7702012
[TBL] [Abstract][Full Text] [Related]
5. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
[TBL] [Abstract][Full Text] [Related]
6. [Immunological effect of recombinant interferon-gamma in renal cell carcinoma].
Kawata N; Ono M; Endo M; Ichinose T; Hamada T; Hirano D; Fuse T; Takimoto Y
Hinyokika Kiyo; 1993 Jun; 39(6):511-5. PubMed ID: 8337976
[TBL] [Abstract][Full Text] [Related]
7. [Effect of interferon alpha on immunologic parameters in patients with carcinoma of the renal parenchyma].
Markinović M; Jelić S; Milosević D; Kovcin V; Spuzić I
Glas Srp Akad Nauka Med; 1994; (44):101-8. PubMed ID: 7590406
[TBL] [Abstract][Full Text] [Related]
8. [Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+ CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma].
Liu CF; Guo Z; Si TG; Xing WG; Liu F; Xing JZ
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):902-5. PubMed ID: 20646510
[TBL] [Abstract][Full Text] [Related]
9. Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma.
Hamada I; Kato M; Yamasaki T; Iwabuchi K; Watanabe T; Yamada T; Itoyama S; Ito H; Okada K
Anticancer Res; 2002; 22(6C):4281-4. PubMed ID: 12553070
[TBL] [Abstract][Full Text] [Related]
10. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
[TBL] [Abstract][Full Text] [Related]
11. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
15. [Immunological study of interferon-gamma therapy for advanced renal cell carcinoma].
Aoyagi T; Murai M; Kimura F; Sawamura M; Asano T; Odajima K; Nagakura K; Nakamura H
Hinyokika Kiyo; 1992 Dec; 38(12):1357-60. PubMed ID: 1288223
[TBL] [Abstract][Full Text] [Related]
16. Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells.
Harlin H; Artz AS; Mahowald M; Rini BI; Zimmerman T; Vogelzang NJ; Gajewski TF
Bone Marrow Transplant; 2004 Mar; 33(5):491-7. PubMed ID: 14716341
[TBL] [Abstract][Full Text] [Related]
17. Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy.
Verra N; de Jong D; Bex A; Batchelor D; Dellemijn T; Sein J; Nooijen W; Meinhardt W; Horenblas S; de Gast G; Vyth-Dreese F
Eur Urol; 2005 Sep; 48(3):527-33. PubMed ID: 16115526
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of postoperative interferon-alpha adjuvant therapy for non-metastatic renal cell carcinoma.
Gotoh A; Shirakawa T; Hinata N; Wada Y; Hara I; Fujisawa M; Kawabata G; Okada H; Arakawa S; Kamidono S
Int J Urol; 2004 May; 11(5):257-63. PubMed ID: 15147539
[TBL] [Abstract][Full Text] [Related]
20. [Immunological effect of recombinant interferon-gamma on tumor infiltrating lymphocytes of renal cell carcinoma--relationship with clinical stage].
Kawata N; Takimoto Y; Hirano D; Yamamoto T; Hirakata H; Yamanaka Y; Okada Y; Chino K; Sugimoto S; Igarashi T
Hinyokika Kiyo; 1996 Jan; 42(1):1-4. PubMed ID: 8686575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
